Core Viewpoint - Crescent Capital BDC (CCAP) is experiencing significant selling pressure, having declined 12% over the past four weeks, but is now positioned for a potential trend reversal as it enters oversold territory, with analysts expecting better earnings than previously predicted [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a key technical indicator used to identify oversold conditions, with a reading below 30 typically indicating that a stock is oversold [2]. - CCAP's current RSI reading is 27.96, suggesting that the heavy selling pressure may be exhausting itself, indicating a potential trend reversal [5]. Group 2: Fundamental Indicators - There is a strong consensus among sell-side analysts that earnings estimates for CCAP will improve, with a 0.9% increase in the consensus EPS estimate over the last 30 days, which often correlates with price appreciation [7]. - CCAP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the stock's potential for a turnaround [8].